"Antineoplastic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
| Descriptor ID |
D000970
|
| MeSH Number(s) |
D27.505.954.248
|
| Concept/Terms |
Antineoplastic Agents- Antineoplastic Agents
- Agents, Antineoplastic
- Antineoplastic Drugs
- Drugs, Antineoplastic
- Antineoplastics
- Chemotherapeutic Anticancer Drug
- Drug, Chemotherapeutic Anticancer
- Antitumor Drugs
- Drugs, Antitumor
- Cancer Chemotherapy Agents
- Agents, Cancer Chemotherapy
- Chemotherapy Agents, Cancer
- Cancer Chemotherapy Drugs
- Chemotherapy Drugs, Cancer
- Drugs, Cancer Chemotherapy
- Chemotherapeutic Anticancer Agents
- Agents, Chemotherapeutic Anticancer
- Anticancer Agents
- Agents, Anticancer
- Antitumor Agents
- Agents, Antitumor
|
Below are MeSH descriptors whose meaning is more general than "Antineoplastic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antineoplastic Agents".
This graph shows the total number of publications written about "Antineoplastic Agents" by people in this website by year, and whether "Antineoplastic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 2 | 9 |
| 1997 | 15 | 1 | 16 |
| 1998 | 15 | 2 | 17 |
| 1999 | 11 | 2 | 13 |
| 2000 | 13 | 5 | 18 |
| 2001 | 9 | 4 | 13 |
| 2002 | 15 | 4 | 19 |
| 2003 | 19 | 5 | 24 |
| 2004 | 12 | 10 | 22 |
| 2005 | 29 | 8 | 37 |
| 2006 | 16 | 17 | 33 |
| 2007 | 15 | 22 | 37 |
| 2008 | 31 | 10 | 41 |
| 2009 | 24 | 22 | 46 |
| 2010 | 30 | 18 | 48 |
| 2011 | 37 | 19 | 56 |
| 2012 | 35 | 16 | 51 |
| 2013 | 42 | 22 | 64 |
| 2014 | 38 | 16 | 54 |
| 2015 | 51 | 32 | 83 |
| 2016 | 65 | 26 | 91 |
| 2017 | 46 | 18 | 64 |
| 2018 | 52 | 23 | 75 |
| 2019 | 51 | 18 | 69 |
| 2020 | 40 | 7 | 47 |
| 2021 | 54 | 16 | 70 |
| 2022 | 19 | 2 | 21 |
| 2023 | 27 | 3 | 30 |
| 2024 | 10 | 19 | 29 |
| 2025 | 44 | 9 | 53 |
| 2026 | 24 | 4 | 28 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antineoplastic Agents" by people in Profiles.
-
Platinum chemotherapy ages the liver. Science. 2026 Sep 10; 393(6816):1081-1082.
-
Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation. Science. 2026 Sep 03; 393(6815):eaec6116.
-
Blinatumomab Care Delivery for Pediatric B-Cell Acute Lymphoblastic Leukemia. JAMA Netw Open. 2026 Sep 01; 9(9):e2632786.
-
Discovery and Development of First-in-Class Cereblon-Recruiting RIPK1 Degraders. J Med Chem. 2026 Aug 27; 69(16):19822-19840.
-
Interfacial lipid digestion-responsive injectable nanoemulsions enhance lapatinib efficacy in triple-negative breast cancer. Colloids Surf B Biointerfaces. 2026 Dec; 268(Pt 2):116079.
-
Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models. Blood. 2026 08 06; 148(6):751-766.
-
Development of a structurally distinct TopBP1 inhibitor that enhances PARP blockade and reverses osimertinib resistance. Sci Adv. 2026 Aug 07; 12(32):eaeg1996.
-
Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma. Mol Cancer Ther. 2026 Aug 04; 25(8):1342-1356.
-
Recurrent Hypoglycemia Following Asparaginase Therapy for Lymphoid Malignancies in Childhood: The Texas Children's Hospital Experience. Pediatr Blood Cancer. 2026 Sep; 73(9):e70457.
-
Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group. Blood Adv. 2026 07 28; 10(14):4923-4930.